Target intelligence / Profile preview

Espin (ESPN)

Target
ESPN
Molecular classification
Other, Cytoskeletal protein, Actin-bundling protein
01

Overview

Espin (ESPN) is a multifunctional, calcium-insensitive actin-bundling protein encoded by the *ESPN* gene in humans[1][3][5]. Espin is primarily associated with the actin-rich microvillus-type specializations such as stereocilia of sensory hair cells in the inner ear, where it is essential for organizing, elongating, and stabilizing parallel actin bundles[1][3][5]. It plays a crucial role in sensory transduction for hearing and balance, and mutations in ESPN disrupt stereocilia structure—causing autosomal recessive (DFNB36) and autosomal dominant non-syndromic sensorineural deafness in humans, and similar defects in mice (jerker phenotype)[1][3][5]. Espin activity depends on multiple interaction domains, including a unique WH2 domain facilitating targeted actin bundle assembly, and is regulated by binding partners like class III myosins[3]. There are no currently approved drugs targeting espin, and it is not considered a clinical therapeutic target. It functions as an essential cytoskeletal structural protein rather than a receptor, enzyme, or canonical drug target[1][3][5].

Other names
DFNB36LP2654Autosomal recessive deafness type 36 proteinEctoplasmic specialization proteinUSH1Mespinectoplasmic specialization protein
02

Biological functions

Actin cytoskeleton organizationSensory transduction (hearing, balance)Regulation of stereocilia and microvilli length/dimensions
03

Disease associations

Hearing loss (autosomal recessive and dominant, DFNB36)Vestibular dysfunctionOther neurosensory disorders linked to cytoskeletal defects
04

Biomarkers

Espin expression level (potential marker for sensory hair cell function)

Beyond the preview

Go deeper on Espin (ESPN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Espin (ESPN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call